Journal of Clinical and Experimental Ophthalmology
Open Access

Eye diseases are among the most important yet frequently underestimated health problems affecting individuals across the world. Vision influences almost every aspect of daily life, including learning, communication, mobility, employment, social participation, and independence. Despite this importance, eye health is often treated as a secondary concern until noticeable visual symptoms appear. In my view, this approach needs to change. Modern eye care should not be defined primarily by its ability to restore vision after disease has developed, but by its capacity to prevent avoidable damage, identify disease at an early stage, and provide appropriate care throughout a person's lifetime. The growing burden of eye diseases, combined with rapid developments in diagnostics and treatment, creates an opportunity to rethink how society approaches visual health.

A major concern is that many eye diseases develop gradually and may initially produce few noticeable symptoms. Glaucoma is an important example. Progressive damage to the optic nerve can occur before a person becomes aware of significant visual loss. Diabetic retinal disease can similarly advance without obvious symptoms, particularly during its earlier stages. Age-related macular degeneration may affect central vision progressively, while cataract can gradually interfere with everyday activities. Because several conditions can remain clinically silent for long periods, waiting for visual complaints before seeking an eye examination is not an ideal strategy. I believe routine eye assessment should be regarded as part of preventive healthcare rather than simply a service for people who already have vision problems.

Prevention should therefore become a central principle of eye health. Some causes of visual impairment are influenced by modifiable risk factors, although not every eye disease can be prevented. Maintaining appropriate control of diabetes and blood pressure, avoiding tobacco exposure, protecting the eyes from injury, practicing appropriate contact lens hygiene, and obtaining recommended eye examinations can reduce certain risks. Public education is particularly important because many people do not recognize that eye diseases may progress without symptoms. Awareness campaigns should emphasize that clear vision does not always mean that the eyes are completely healthy.

Children also deserve greater attention within discussions of eye disease. Visual development during childhood is closely connected with learning and social development. Conditions such as uncorrected refractive errors, amblyopia, strabismus, congenital abnormalities, and certain retinal or corneal disorders can affect visual development if they are not recognized at an appropriate stage. Schools and primary healthcare services can play an important role in identifying children who require professional assessment. In my opinion, childhood vision screening should be integrated more effectively into broader child-health programs rather than treated as an isolated activity.

Treatment itself is also changing. Traditional approaches remain important, but newer medicines, sustained drug-delivery systems, minimally invasive procedures, advanced intraocular lenses, and regenerative strategies are expanding the therapeutic possibilities. These developments are particularly encouraging for diseases that previously had limited treatment options. However, the existence of a new therapy does not automatically mean that it is the best choice for every patient. Treatment decisions should consider effectiveness, safety, affordability, adherence, expected duration of benefit, and the patient's individual priorities. In my view, personalized decision-making is more valuable than simply adopting the newest available technology.

Eye diseases will remain a major challenge as populations age, chronic diseases increase, and expectations for high-quality healthcare continue to grow. Yet the future is also promising. Better imaging, artificial intelligence, molecular research, targeted therapies, surgical advances, and improved public-health strategies provide opportunities to reduce avoidable visual impairment. The success of these efforts should ultimately be measured not by the number of technologies developed but by the number of people who retain useful vision and independence. A modern approach to eye disease must therefore place scientific progress alongside accessibility, prevention, compassion, and patient-centered decision-making.